Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Global Tetrodotoxin Citrate Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.
The global Tetrodotoxin citrate market is anticipated to grow at a considerable CAGR during the forecast period. The launch of novel medications, as well as therapeutic agents for pain relief in appropriate doses, are some elements propelling the market growth. Tetrodotoxin is a neurotoxin generated from the sea that blocks nerve and muscle action potentials by reversibly inhibiting the inward sodium current through voltage-activated sodium (Nav) channels.
The global Tetrodotoxin citrate market is segmented based on type and application. Based on type, the Tetrodotoxin citrate market is segmented into high purity (above 99%), low purity (below 97%), purity (above 97% and below 99%) Tetrodotoxin citrate. Based on application, the Tetrodotoxin citrate market is segmented into medical treatment, bioscience research, and others.
Geographically, the global tetrodotoxin citrate market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global Tetrodotoxin citrate market include R&D Systems, Enzo Life Sciences, and Tocris Bioscience, among others.
Market Segmentation
- Global Tetrodotoxin Citrate Market Research and Analysis by Type
- Global Tetrodotoxin Citrate Market Research and Analysis by Application
The Report Covers
- Comprehensive research methodology of the global tetrodotoxin citrate market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global tetrodotoxin citrate market.
- Insights about market determinants that are stimulating the global tetrodotoxin citrate market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Tetrodotoxin Citrate Market by Type
4.1.1. High Purity (Above 99%)
4.1.2. Low Purity (Below 97%)
4.1.3. Purity (Below 99% and Above 97%)
4.2. Global Tetrodotoxin Citrate Market by Application
4.2.1. Medical treatment
4.2.2. Bioscience Research
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abcam Plc
6.2. Alfa Chemistry
6.3. Anward
6.4. Aurum Pharmatech LLC
6.5. Cayman Chemical Co.
6.6. Enzo Lifesciences
6.7. Glentham Life Sciences
6.8. R&D Systems, Inc.
6.9. Race Chemical Shanghai Race Chemical Co., Ltd.
6.10. Santa Cruz Biotechnology, Inc.
6.11. STEMCELL Technologies Inc.
6.12. Stemgent, Inc.
6.13. Tocris Bioscience
For more information about this report visit https://www.researchandmarkets.com/r/xcoda6
